IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

APIs Will Drive Growth in Contract Manufacturing

7:52 AM MDT | September 25, 2012 | Deepti Ramesh

The manufacture of active pharmaceutical ingredients (APIs) will account for the majority of revenues in the pharmaceutical contract manufacturing industry in the next 10 years, says a recent report by business information provider Visiongain (London). The report predicts that the global market for pharmaceutical contract manufacturing will be worth $47.6 billion in 2012; and between 2011 and 2016, the overall market will grow at a compound annual growth rate of over 6%. API manufacturing formed the largest sector in pharmaceutical contract manufacturing in 2011...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa